Cite
HARVARD Citation
Madan, R. et al. (2021). Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer. BJU international. pp. 435-444. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Madan, R. et al. (2021). Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer. BJU international. pp. 435-444. [Online].